Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis

[1]  D. McMillan,et al.  The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer , 2004, British Journal of Cancer.

[2]  G. Rice,et al.  Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer , 2004, British Journal of Cancer.

[3]  G. Omenn.  Human lung cancer chemoprevention strategies: Parker B. Francis lecture. , 2004, Chest.

[4]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[5]  A. Tall.  C-reactive protein reassessed. , 2004, The New England journal of medicine.

[6]  Paul Lizardi,et al.  Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements , 2004, Genome Biology.

[7]  Zhifu Sun,et al.  Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. , 2004, The Lancet. Oncology.

[8]  X. Xiao,et al.  Development of Proteomic Patterns for Detecting Lung Cancer , 2004, Disease markers.

[9]  T. Yip,et al.  Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker to Monitor Relapse of Nasopharyngeal Cancer by Serum Proteomic Profiling , 2004, Clinical Cancer Research.

[10]  B. Haab.  Methods and applications of antibody microarrays in cancer research , 2003, Proteomics.

[11]  M. Price,et al.  Tissue and Serum MUC1 Mucin Detection in Breast Cancer Patients , 2003, Breast Cancer Research and Treatment.

[12]  S. Gygi,et al.  Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry , 2003 .

[13]  T. Zhukov,et al.  Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. , 2003, Lung cancer.

[14]  E. B. Butler,et al.  Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers , 2003, Proteomics.

[15]  S. Dudoit,et al.  Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data , 2002 .

[16]  T. Barrette,et al.  Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. , 2001, Cancer research.

[17]  Y. Tomita,et al.  Significance of serum amyloid a on the prognosis in patients with renal cell carcinoma , 2001, Cancer.

[18]  L. Liotta,et al.  Proteomic profiling of the cancer microenvironment by antibody arrays , 2001, Proteomics.

[19]  G. M. D'eril,et al.  Biological variation of serum amyloid A in healthy subjects. , 2001, Clinical chemistry.

[20]  K Sugimachi,et al.  Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. , 2001, American journal of surgery.

[21]  M. Gerstein,et al.  Global Analysis of Protein Activities Using Proteome Chips , 2001, Science.

[22]  R. Huang,et al.  Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. , 2001, Analytical biochemistry.

[23]  P. Brown,et al.  Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions , 2001, Genome Biology.

[24]  I. Glojnarić,et al.  Serum Amyloid A Protein (SAA) in Colorectal Carcinoma , 2001, Clinical chemistry and laboratory medicine.

[25]  S. Schreiber,et al.  Printing proteins as microarrays for high-throughput function determination. , 2000, Science.

[26]  I. Tomlinson,et al.  Antibody arrays for high-throughput screening of antibody–antigen interactions , 2000, Nature Biotechnology.

[27]  S. Kingsmore,et al.  Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Igishi,et al.  [The value of serum C-reactive protein as a survival determinant in patients with advanced non-small-cell lung cancer]. , 2000, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[29]  Dieter Stoll,et al.  A microarray enzyme‐linked immunosorbent assay for autoimmune diagnostics , 2000, Electrophoresis.

[30]  A. Mirzabekov,et al.  Protein microchips: use for immunoassay and enzymatic reactions. , 2000, Analytical biochemistry.

[31]  H. Ge,et al.  UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. , 2000, Nucleic acids research.

[32]  L. G. Mendoza,et al.  High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA). , 1999, BioTechniques.

[33]  H. Lehrach,et al.  Protein microarrays for gene expression and antibody screening. , 1999, Analytical biochemistry.

[34]  T. Mitsudomi,et al.  MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence. , 1999, The Annals of thoracic surgery.

[35]  A. Harris,et al.  MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients. , 1998, Journal of clinical pathology.

[36]  J. Jass,et al.  Significance of MUC1 and MUC2 mucin expression in colorectal cancer. , 1996, Journal of clinical pathology.

[37]  C. McArdle,et al.  The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. , 1996, British Journal of Cancer.

[38]  J. Wesseling,et al.  A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. , 1996, Molecular biology of the cell.

[39]  Y. Nakanuma,et al.  Pathological and immunohistochemical findings in a case of mucinous cholangiocarcinoma , 1995, Pathology international.

[40]  A. Sonnenberg,et al.  Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components , 1995, The Journal of cell biology.

[41]  Walsh,et al.  Prognostic significance of MUC1 epithelial mucin expression in breast cancer. , 1995, Human pathology.

[42]  R. Stahel,et al.  Biology of lung cancer. , 1994, Lung cancer.

[43]  D. Ota,et al.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. , 1994, Gastroenterology.

[44]  P. Souquet,et al.  [Value of C-reactive protein determination in small cell lung cancer]. , 1993, Bulletin du cancer.

[45]  I. Ellis,et al.  Expression of tumour-associated antigens in breast cancer primary tissue compared with serum levels. , 1993, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[46]  D. Pee,et al.  Serum mucin antigens casa and msa in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients , 1993, Cancer.

[47]  R. Dahiya,et al.  Heterogeneity of mucin gene expression in normal and neoplastic tissues. , 1993, Cancer research.

[48]  F. Sarkar,et al.  Genetic markers as prognostic indicators in breast cancer , 1992, Cancer.

[49]  M. Higashiyama,et al.  An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis. , 1992, British Journal of Cancer.

[50]  J. Raynes,et al.  Acute‐phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin‐1 and interleukin‐6 , 1991, Clinical and experimental immunology.

[51]  N. Peat,et al.  Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. , 1990, The Journal of biological chemistry.

[52]  M. Pras,et al.  Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis. , 1986, Journal of clinical pathology.

[53]  D. Hayes,et al.  Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. , 1985, The Journal of clinical investigation.

[54]  M. Skinner,et al.  Acute‐Phase Proteins or Tumour Markers: The Role of SAA, SAP, CRP and CEA as Indicators of Metastasis in a Broad Spectrum of Neoplastic Diseases , 1984, Scandinavian journal of immunology.

[55]  L. Bausserman,et al.  Rapid clearance of serum amyloid A from high-density lipoproteins. , 1984, Biochimica et biophysica acta.

[56]  L. Sullivan,et al.  Serum amyloid A to monitor cancer dissemination. , 1979, Annals of internal medicine.

[57]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[58]  B. Haab,et al.  Multiplexed protein analysis using spotted antibody microarrays. , 2004, Methods in molecular biology.

[59]  J. Kaneti,et al.  Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer , 2004, Urological Research.

[60]  S. Gygi,et al.  Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[61]  Y. Kim,et al.  Membrane-bound (MUC1) and secretory (MUC2, MUC3, and MUC4) mucin gene expression in human lung cancer. , 1996, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[62]  S. Gendler,et al.  Epithelial mucin genes. , 1995, Annual review of physiology.

[63]  R. Crystal.  The alpha 1-antitrypsin gene and its deficiency states. , 1989, Trends in genetics : TIG.

[64]  R. Crystal.  The α1-antitrypsin gene and its deficiency states , 1989 .

[65]  J. Homolka,et al.  [Significance of alpha-1-antitrypsin and alpha-2-pregnancy-associated glycoprotein in the serum of patients with bronchial carcinoma]. , 1987, Zeitschrift fur Erkrankungen der Atmungsorgane.

[66]  A. Bizzarro,et al.  [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)]. , 1982, Bollettino dell'Istituto sieroterapico milanese.

[67]  M. Benson,et al.  Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. , 1979, Arthritis and rheumatism.